Caveolin-1 triggers T-cell activation via CD26 in association with CARMA1
about
The Role of Dipeptidyl Peptidase - 4 Inhibitors in Diabetic Kidney DiseaseRecent Advances in Dipeptidyl-Peptidase-4 Inhibition Therapy: Lessons from the Bench and Clinical TrialsEffect of a dipeptidyl peptidase-IV inhibitor, des-fluoro-sitagliptin, on neointimal formation after balloon injury in ratsRegulation of somatostatin receptor 4-mediated cytostatic effects by CD26 in malignant pleural mesotheliomaThe nonglycemic actions of dipeptidyl peptidase-4 inhibitorsThe dimeric transmembrane domain of prolyl dipeptidase DPP-IV contributes to its quaternary structure and enzymatic activities.Design, Assessment, and in vivo Evaluation of a Computational Model Illustrating the Role of CAV1 in CD4(+) T-lymphocytes.Nuclear localization of CD26 induced by a humanized monoclonal antibody inhibits tumor cell growth by modulating of POLR2A transcriptionFibroblast activation protein (FAP) is essential for the migration of bone marrow mesenchymal stem cells through RhoA activationDipeptidyl-peptidase-4 inhibitor, alogliptin, attenuates arterial inflammation and neointimal formation after injury in low-density lipoprotein (LDL) receptor-deficient mice.Conserved Molecular Underpinnings and Characterization of a Role for Caveolin-1 in the Tumor Microenvironment of Mature T-Cell Lymphomas.Regulation of pulmonary graft-versus-host disease by IL-26+CD26+CD4 T lymphocytes.Caveolin-1 signaling in lung fibrosis.Dipeptidyl peptidase-4 is highly expressed in bronchial epithelial cells of untreated asthma and it increases cell proliferation along with fibronectin production in airway constitutive cells.Dipeptidyl peptidase-4: a key player in chronic liver disease.Loss of TCR-beta F1 and/or EZRIN expression is associated with unfavorable prognosis in nodal peripheral T-cell lymphomas.A humanized anti-CD26 monoclonal antibody inhibits cell growth of malignant mesothelioma via retarded G2/M cell cycle transition.Versatile Functions of Caveolin-1 in Aging-related Diseases.The dipeptidyl peptidase IV family in cancer and cell biology.Caveolin-1: a critical regulator of lung injury.Incretin-based therapies--review of the physiology, pharmacology and emerging clinical experience.Recent patents of dipeptidyl peptidase IV inhibitors.Effects of pioglitazone and vildagliptin on coagulation cascade in diabetes mellitus--targeting thrombogenesis.The role of CARMA1 in T cells.Role of caveolin-1 in asthma and chronic inflammatory respiratory diseases.Cut to the chase: a review of CD26/dipeptidyl peptidase-4's (DPP4) entanglement in the immune system.CD26 and Asthma: a Comprehensive Review.Integrated inference and evaluation of host-fungi interaction networks.Effects of dipeptidyl peptidase-4 inhibition in an animal model of experimental asthma: a matter of dose, route, and timeInhibition of Middle East respiratory syndrome coronavirus infection by anti-CD26 monoclonal antibody.SMAD4 loss enables EGF, TGFβ1 and S100A8/A9 induced activation of critical pathways to invasion in human pancreatic adenocarcinoma cellsCD26-mediated co-stimulation in human CD8(+) T cells provokes effector function via pro-inflammatory cytokine production.Phenotyping of congenic dipeptidyl peptidase 4 (DP4) deficient Dark Agouti (DA) rats suggests involvement of DP4 in neuro-, endocrine, and immune functions.CD26: a negative selection marker for human Treg cells.CD26/dipeptidyl peptidase 4-deficiency alters thymic emigration patterns and leukcocyte subsets in F344-rats age-dependently.Nuclear pore complex-mediated modulation of TCR signaling is required for naïve CD4+ T cell homeostasis.Research advances in metabolism 2016.SV-BR-1-GM, a Clinically Effective GM-CSF-Secreting Breast Cancer Cell Line, Expresses an Immune Signature and Directly Activates CD4+ T Lymphocytes.Is there a Chance to Promote Arteriogenesis by DPP4 Inhibitors Even in Type 2 Diabetes? A Critical Review
P2860
Q26784454-4B565F43-9958-41D0-A1EC-F68CCB9FBEA7Q28081569-41AB88B8-CCC2-4734-8E81-877474696FABQ28730724-2B719734-C578-42FB-A901-7697CDD4BEE7Q33555260-E91F7077-C50D-44B1-9B3C-879831A46DA1Q34029715-70808D4C-31F6-41A5-A600-5499421694DBQ34284911-357CE68C-4058-486A-A151-ABD6B8973236Q34637731-48F662D3-BB15-49CB-96F1-DBE877E4CB77Q34701204-71AFCE69-572D-494B-BE32-736D59C88DD7Q35097559-71964216-1B39-4EBC-B08C-218652917414Q35353937-1BDF4A4E-13F1-4CF6-B679-B63634DF1CCDQ35840904-CDFA0318-9BE9-4DDC-B3DA-019980C0CF6FQ36056986-60775230-843B-4F2E-ACD0-94056DDF7F9FQ36093857-6EDC3A99-AC92-4EAD-8268-31D9BFEC9129Q36687153-789FFBDE-6736-4CED-BDB8-F1A1A70474FDQ36783164-62B0F6AB-06BB-4141-AB20-B7BF5D99BE02Q36809448-9E89EFFE-03FE-4E1C-8F50-5A2E227D2787Q36853747-25030050-4684-4944-9E33-240E996AC93AQ37633081-24C1E0BC-6663-4E56-BB82-253BF5FB2B26Q37674999-571611D5-20C1-49E7-9AB3-49F4E7F813D1Q37811611-CD96E29C-FF5E-4C32-809E-4CF360DEB471Q37837059-9B33A43C-35CE-478D-A3BD-F1D687EE4DB0Q37948110-FA2873CE-FE19-4EE1-837C-942D94BF9B6EQ38077284-B89CF934-4857-4EC7-9821-000279B2505EQ38113623-53BF3B7D-981F-4CFD-82A2-B268966A5424Q38205256-919C99E7-BE58-4B50-A196-006BD34F2E52Q38751579-57E6DC6E-D2CF-40FB-8D04-6D193BC9C183Q38937243-B4E9A805-76FD-46C8-B377-AB05C52EFAE6Q38971569-C2ACD7F3-B503-4BF1-8943-75D43BC131C1Q41866098-A5E2B019-86F7-4612-8454-30D48B066969Q41920484-B0A28F77-6C7E-494B-B782-029A67E5CC18Q41959768-8BC2F73A-F91C-4C60-B7C3-978443888D93Q44561307-30F13624-847C-4464-9CFD-927B0A3E9270Q46071696-45C1BFE5-2A23-4A56-B4F4-9527FD167B34Q46762458-82D1C887-9A09-4B84-9BF2-4FC67982FA36Q51960207-0999A6DC-646F-4F06-A334-06F7443C5AAAQ54218745-48A17B8E-ECD3-406B-A7FE-BA3892590ABBQ55257391-899DF8C5-5C31-4D70-A600-DA2A2D491080Q55342016-7F8C1F2E-8BAF-4A3B-B258-22051A1ED41AQ58579298-CE167FCA-155D-48ED-BEF4-0514A6027E6B
P2860
Caveolin-1 triggers T-cell activation via CD26 in association with CARMA1
description
2007 nî lūn-bûn
@nan
2007 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մարտին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Caveolin-1 triggers T-cell activation via CD26 in association with CARMA1
@ast
Caveolin-1 triggers T-cell activation via CD26 in association with CARMA1
@en
Caveolin-1 triggers T-cell activation via CD26 in association with CARMA1
@en-gb
Caveolin-1 triggers T-cell activation via CD26 in association with CARMA1
@nl
type
label
Caveolin-1 triggers T-cell activation via CD26 in association with CARMA1
@ast
Caveolin-1 triggers T-cell activation via CD26 in association with CARMA1
@en
Caveolin-1 triggers T-cell activation via CD26 in association with CARMA1
@en-gb
Caveolin-1 triggers T-cell activation via CD26 in association with CARMA1
@nl
prefLabel
Caveolin-1 triggers T-cell activation via CD26 in association with CARMA1
@ast
Caveolin-1 triggers T-cell activation via CD26 in association with CARMA1
@en
Caveolin-1 triggers T-cell activation via CD26 in association with CARMA1
@en-gb
Caveolin-1 triggers T-cell activation via CD26 in association with CARMA1
@nl
P2093
P2860
P921
P3181
P356
P1476
Caveolin-1 triggers T-cell activation via CD26 in association with CARMA1
@en
P2093
Chikao Morimoto
Hirotoshi Tanaka
Kei Ohnuma
Kunika Nishibashi
Masahiko Uchiyama
Nam H Dang
Nozomu Takahashi
Osamu Hosono
Shinichiro Kina
Tadanori Yamochi
P2860
P304
P3181
P356
10.1074/JBC.M609157200
P407
P577
2007-03-30T00:00:00Z